Pharmacists in Jacksonville, Florida
1110 Pharmacists found in Jacksonville
Dr. Michael Alvis Cleveland, PHARMD
Pharmacist
2080 Child St, Naval Hospital Jacksonville Pharmacy Dept, Jacksonville, FL 32214
904-542-7406
Mr. Michael Joseph Stophel, RPH
Pharmacist
10490 San Jose Blvd, Jacksonville, FL 32257
904-268-3995 904-268-3995
Dr. Michael J. Schuh, BS, PHARMD, MBA
Pharmacist
4500 San Pablo Rd S, Schuh.michael@mayo.edu, Jacksonville, FL 32224
904-953-2021 904-953-2274
Dr. Michele Schwebel Smith, PHARM.D.
Pharmacist
4500 San Pablo Rd S, Email: Smith.michele@mayo.edu, Jacksonville, FL 32224
904-953-2204 904-953-2274
Dr. Michele Marie Loudy, PHARMD
Pharmacist
1 Shircliff Way, Jacksonville, FL 32204
904-308-8829 904-308-2980
Michelle Renee Lowe, PHARMD
Pharmacist
3604 Blanding Blvd, Jacksonville, FL 32210
904-778-8821 904-778-9053
Dr. Michelle Deviere Trout, MPH, PHARMD
Pharmacist
655 W 8th St, Jacksonville, FL 32209
904-244-3000
Ms. Michelle Birt, RPH
Pharmacist
11135 Lem Turner Rd, Jacksonville, FL 32218
904-764-8918 904-764-5611
Minh P Nguyen, PHARMD
Pharmacist
7990 Baymeadows Rd E Unit 1105, Jacksonville, FL 32256
727-666-0400
Minh Thu Thi Tran, PHARMACIST
Pharmacist
6005 Saint Augustine Rd, Jacksonville, FL 32217
904-733-7600
Minhchau Thi Vo, RPH
Pharmacist
11380 Beach Blvd Ste 6, Jacksonville, FL 32246
904-996-0888 904-998-7007
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.